Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma.

Trial Profile

Phase II Study of ZK 219477 in Patients With Recurrent Glioblastoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2012

At a glance

  • Drugs Sagopilone (Primary)
  • Indications Glioblastoma
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 21 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Jul 2012 Additional trial locations identified as reported by European Clinical Trials Database.
    • 07 Sep 2007 Status change from recruiting to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top